Application of intragenic DNA probes in prenatal screening for retinoblastoma gene carriers in the United Kingdom.
Department of Haematology and Oncology, Institute of Child Health, London.
Restriction fragment length polymorphisms (RFLPs) in 55 families affected by retinoblastoma have been studied using recombinant DNA probes derived from within the retinoblastoma predisposition gene. Only six families were uninformative for any of the DNA polymorphisms. The remaining 49 families can be offered prenatal screening. No obligate recombinations between any of the polymorphic loci and the retinoblastoma phenotype were observed. Four previously unknown cases of non-penetrance were identified. Prenatal testing for the inheritance of mutant alleles was performed in two cases and perinatal screening in two additional cases. One fetus inherited the normal allele from the affected parent and is therefore not at risk of retinoblastoma; the second fetus inherited the mutant allele and will require frequent screening for early detection of retinoblastoma. Both perinatal tests showed the absence of the mutant allele.
This article has been cited by other articles:
-
MacCarthy, A, Birch, J M, Draper, G J, Hungerford, J L, Kingston, J E, Kroll, M E, Onadim, Z, Stiller, C A, Vincent, T J, Murphy, M F G
(2009). Retinoblastoma in Great Britain 1963-2002. Br J Ophthalmol
93: 33-37
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



